Mutation of Ha-Ras C terminus changes effector pathway utilization

被引:23
作者
Booden, MA
Sakaguchi, DS
Buss, JE
机构
[1] Iowa State Univ Sci & Technol, Dept Biochem Biophys & Mol Biol, Ames, IA 50011 USA
[2] Iowa State Univ Sci & Technol, Dept Zool Genet, Ames, IA 50011 USA
[3] Iowa State Univ Sci & Technol, Signal Transduct Training Grp, Ames, IA 50011 USA
关键词
D O I
10.1074/jbc.M001368200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
In PC12 cells, Ha-Ras modulates multiple effector proteins that induce neuronal differentiation. To regulate these pathways Ha-nas must be located at the plasma membrane, a process normally requiring attachment of farnesyl and palmitate lipids to the C terminus. Ext61L, a constitutively activated and palmitoylated Ha-Res that lacks a farnesyl group, induced neurites with more actin cytoskeletal changes and lamellipodia than were induced by farnesylated Ha-Ras61L, Ext61L-triggered neurite outgrowth was prevented easily by co-expressing inhibitory Rho, Cdc42, or p21-activated kinase but required increased amounts of inhibitory Rac, Compared with Ha-Ras61L, Ext61L caused a-fold greater Rac GTP binding and phosphatidylinositol 3-kinase activity in membranes, a hyperactivation that explained the numerous lamellipodia and ineffectiveness of Rac(N17), In contrast, Ext61L activated B-Raf kinase and ERK phosphorylation more poorly than Ha-Ras61L, Thus, accentuated differentiation by Ext61L apparently results from heightened activation of one Ras effector (phosphatidylinositol 3-kinase) and suboptimal activation of another (B-Raf). This surprising unbalanced effector activation, without changes in the designated Res effector domain, indicates the Ext61L C-terminal alternations are a new way to influence Ha-Res-effector utilization and suggest a broader role of the lipidated C terminus in Ha-Res biological functions.
引用
收藏
页码:23559 / 23568
页数:10
相关论文
共 69 条
[1]   Phosphoinositide 3-kinase-dependent and -independent activation of the small GTPase Rac2 in human neutrophils [J].
Akasaki, T ;
Koga, H ;
Sumimoto, H .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (25) :18055-18059
[2]   Characterization of a 3-phosphoinositide-dependent protein kinase which phosphorylates and activates protein kinase B alpha [J].
Alessi, DR ;
James, SR ;
Downes, CP ;
Holmes, AB ;
Gaffney, PRJ ;
Reese, CB ;
Cohen, P .
CURRENT BIOLOGY, 1997, 7 (04) :261-269
[3]   PD-098059 IS A SPECIFIC INHIBITOR OF THE ACTIVATION OF MITOGEN-ACTIVATED PROTEIN-KINASE KINASE IN-VITRO AND IN-VIVO [J].
ALESSI, DR ;
CUENDA, A ;
COHEN, P ;
DUDLEY, DT ;
SALTIEL, AR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (46) :27489-27494
[4]   Bioorganic synthesis of lipid-modified proteins for the study of signal transduction [J].
Bader, B ;
Kuhn, K ;
Owen, DJ ;
Waldmann, H ;
Wittinghofer, A ;
Kuhlmann, J .
NATURE, 2000, 403 (6766) :223-226
[5]  
BANSAL VS, 1990, J BIOL CHEM, V265, P1806
[6]   MICROINJECTION OF THE RAS ONCOGENE PROTEIN INTO PC12 CELLS INDUCES MORPHOLOGICAL-DIFFERENTIATION [J].
BARSAGI, D ;
FERAMISCO, JR .
CELL, 1985, 42 (03) :841-848
[7]   RAS MEMBRANE TARGETING IS ESSENTIAL FOR GLUCOSE SIGNALING BUT NOT FOR VIABILITY IN YEAST [J].
BHATTACHARYA, S ;
CHEN, L ;
BROACH, JR ;
POWERS, S .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (07) :2984-2988
[8]   A non-farnesylated Ha-Ras protein can be palmitoylated and trigger potent differentiation and transformation [J].
Booden, MA ;
Baker, TL ;
Solski, PA ;
Der, CJ ;
Punke, SG ;
Buss, JE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (03) :1423-1431
[9]   The structural basis of the activation of Ras by Sos [J].
Boriack-Sjodin, PA ;
Margarit, SM ;
Bar-Sagi, D ;
Kuriyan, J .
NATURE, 1998, 394 (6691) :337-343
[10]   2 DISTINCT RAF DOMAINS MEDIATE INTERACTION WITH RAS [J].
BRTVA, TR ;
DRUGAN, JK ;
GHOSH, S ;
TERRELL, RS ;
CAMPBELLBURK, S ;
BELL, RM ;
DER, CJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (17) :9809-9812